We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+5.81%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$32.7B
AUM Growth
+$3.39B
(+12%)
Cap. Flow
+$2.02B
Cap. Flow
% of AUM
6.18%
Top 10 Holdings %
Top 10 Hldgs %
20.34%
Holding
1,273
New
114
Increased
570
Reduced
394
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$437M |
| 2 |
Intuit
INTU
|
+$333M |
| 3 |
Mastercard
MA
|
+$203M |
| 4 |
Booking.com
BKNG
|
+$186M |
| 5 |
Alibaba
BABA
|
+$155M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$290M |
| 2 |
Akamai
AKAM
|
+$278M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$264M |
| 4 |
Cognizant
CTSH
|
+$252M |
| 5 |
Acuity Brands
AYI
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.14% |
| 2 | Financials | 16.99% |
| 3 | Healthcare | 14.67% |
| 4 | Consumer Discretionary | 12.2% |
| 5 | Communication Services | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JNCE
426
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $4.28M | 0.01% |
305,058
+17,953
| +6% | +$384K |
|
427
Duke Energy
DUK
$101B
| $4.27M | 0.01% |
51,034
+7,940
| +18% | +$667K |
|
428
GSK
GSK
$101B
| $4.24M | 0.01% |
78,593
-760
| -1% | -$40.5K |
|
429
America Movil
AMX
$78.4B
| $4.2M | 0.01% |
+263,553
| New | +$4.09M |
|
430
Harley-Davidson
HOG
$2.73B
| $4.16M | 0.01% |
77,060
-424
| -0.5% | -$23.6K |
|
|
EV
431
DELISTED
Eaton Vance Corp.
EV
| $4.16M | 0.01% |
87,870
-4,706
| -5% | -$214K |
|
|
ORIT
432
DELISTED
Oritani Financial Corp. New
ORIT
| $4.15M | 0.01% |
243,648
-44,509
| -15% | -$752K |
|
433
iShares Biotechnology ETF
IBB
$9.32B
| $4.14M | 0.01% |
40,101
-17,889
| -31% | -$1.76M |
|
434
Truist Financial
TFC
$62.2B
| $4.14M | 0.01% |
91,220
-5,913
| -6% | -$257K |
|
435
Texas Instruments
TXN
$255B
| $4.11M | 0.01% |
53,405
+712
| +1% | +$57.1K |
|
436
Gilead Sciences
GILD
$161B
| $4.09M | 0.01% |
57,740
-19,951
| -26% | -$1.33M |
|
|
DFS
437
DELISTED
Discover Financial Services
DFS
| $4.02M | 0.01% |
64,681
+23,616
| +58% | +$1.46M |
|
438
AvalonBay Communities
AVB
$27.1B
| $4.02M | 0.01% |
20,929
+2,226
| +12% | +$426K |
|
|
FIT
439
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $4.02M | 0.01% |
756,428
+122,342
| +19% | +$678K |
|
440
Alarm.com
ALRM
$2.5B
| $4.02M | 0.01% |
106,726
-44,606
| -29% | -$1.49M |
|
441
General Motors
GM
$72B
| $4M | 0.01% |
114,421
+80,064
| +233% | +$2.72M |
|
442
CME Group
CME
$91.7B
| $3.89M | 0.01% |
31,048
+4,257
| +16% | +$509K |
|
|
ELME
443
Elme Communities
ELME
$132M
| $3.88M | 0.01% |
121,667
-9,111
| -7% | -$293K |
|
444
PPG Industries
PPG
$25.3B
| $3.87M | 0.01% |
35,215
-105
| -0.3% | -$11.4K |
|
445
Cigna
CI
$75.8B
| $3.85M | 0.01% |
23,035
+1,976
| +9% | +$317K |
|
446
Eaton
ETN
$160B
| $3.83M | 0.01% |
49,253
-18,953
| -28% | -$1.44M |
|
447
White Mountains Insurance
WTM
$5.38B
| $3.82M | 0.01% |
4,401
-458
| -9% | -$397K |
|
448
Metallus
MTUS
$851M
| $3.82M | 0.01% |
248,240
| – | – |
|
449
Hewlett Packard
HPE
$63.3B
| $3.76M | 0.01% |
292,050
+264,580
| +963% | +$3.68M |
|
450
KKR & Co
KKR
$85.7B
| $3.71M | 0.01% |
199,481
-990
| -0.5% | -$18.1K |
|
Similar funds
QCM
Brown Advisory's Q2 2017 Portfolio in Review
As of Q2 2017, Brown Advisory held 1,273 positions worth $32.7B, up 12% from $29.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Brown Advisory deployed $2.02B of net new capital in Q2 2017, opening 114 new positions and adding to 570 existing holdings. Its largest new stake was Altaba Inc: 2,311,186 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $290M trimmed.
- Brown Advisory's largest Q2 2017 buy was Altaba Inc: 2,311,186 shares worth $126M.
- Brown Advisory added most to Zoetis in Q2 2017, an estimated $437M increase.
- Brown Advisory's biggest Q2 2017 reduction was Alexion Pharmaceuticals, cutting an estimated $290M.
- Brown Advisory fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $264M.
- Brown Advisory's ten largest holdings make up 20% of its $32.7B portfolio in Q2 2017.
- Brown Advisory opened 114 new positions and closed 56 in Q2 2017.
- Brown Advisory's portfolio value rose 12% quarter-over-quarter to $32.7B.
Based on Brown Advisory's 13F filing for Q2 2017, filed 14 Aug 2017.